These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15846286)

  • 1. What role is there for antithymocyte globulin in allogeneic nonmyeloablative canine hematopoietic cell transplantation?
    Diaconescu R; Little MT; Leisenring W; Yunusov M; Hogan WJ; Sorror ML; Baron F; Storb R
    Biol Blood Marrow Transplant; 2005 May; 11(5):335-44. PubMed ID: 15846286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation.
    Grosskreutz C; Ross V; Scigliano E; Fruchtman S; Isola L
    Biol Blood Marrow Transplant; 2003 Jul; 9(7):453-9. PubMed ID: 12869959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation.
    Jochum C; Beste M; Zellmer E; Graves SS; Storb R
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):164-71. PubMed ID: 17241922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of extending the duration of postgrafting immunosuppression and substituting granulocyte-colony-stimulating factor-mobilized peripheral blood mononuclear cells for marrow in allogeneic engraftment in a nonmyeloablative canine transplantation model.
    Zaucha JM; Yu C; Zellmer E; Takatu A; Junghanss C; Little MT; Storb R
    Biol Blood Marrow Transplant; 2001; 7(9):513-6. PubMed ID: 11669218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Radiation Dose and Low Cell Dose Increase the Risk of Graft Rejection in a Canine Hematopoietic Stem Cell Transplantation Model.
    Lange S; Steder A; Glass Ä; Killian D; Wittmann S; Machka C; Werner J; Schäfer S; Roolf C; Junghanss C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):637-643. PubMed ID: 26802322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of immunological approaches to enhance engraftment in a 1 Gy TBI canine hematopoietic stem cell transplantation model.
    Lange S; Altmann S; Brandt B; Adam C; Riebau F; Vogel H; Weirich V; Hilgendorf I; Storb R; Freund M; Junghanss C
    Exp Hematol; 2009 Jan; 37(1):143-50. PubMed ID: 19100524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation.
    Sorror ML; Leisenring W; Mielcarek M; Baron F; Diaconescu R; Hogan WJ; Graves SS; Storb R
    Transplantation; 2008 Apr; 85(7):1023-9. PubMed ID: 18408584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model.
    Fukuda T; Kerbauy FR; Gooley T; Santos EB; Storb R; Sandmaier BM
    Transplantation; 2006 Aug; 82(3):332-9. PubMed ID: 16906030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged allogeneic marrow engraftment following nonmyeloablative conditioning using 100 cGy total body irradiation and pentostatin before and pharmacological immunosuppression after transplantation.
    Panse JP; Storb R; Storer B; Santos EB; Wentzel C; Sandmaier BM
    Transplantation; 2005 Nov; 80(10):1518-21. PubMed ID: 16340800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation.
    Lee WS; Suzuki Y; Graves SS; Iwata M; Venkataraman GM; Mielcarek M; Peterson LJ; Ikehara S; Torok-Storb B; Storb R
    Biol Blood Marrow Transplant; 2011 Apr; 17(4):465-75. PubMed ID: 20457265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing high and low total body irradiation dose rates for minimum-intensity conditioning of dogs for dog leukocyte antigen-identical bone marrow grafts.
    Graves SS; Storer BE; Butts TM; Storb R
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1650-4. PubMed ID: 23994246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What role for FTY720, a novel immunosuppressive agent, in canine nonmyeloablative hematopoietic stem cell transplantation?
    Xun CQ; Little MT; Zellmer E; Yu C; Zaucha JM; Sale GE; Storer B; Storb R
    Transplantation; 2002 Jan; 73(2):310-3. PubMed ID: 11821753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant.
    Storb R; Yu C; Zaucha JM; Deeg HJ; Georges G; Kiem HP; Nash RA; McSweeney PA; Wagner JL
    Blood; 1999 Oct; 94(7):2523-9. PubMed ID: 10498626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model.
    Sandmaier BM; Fukuda T; Gooley T; Yu C; Santos EB; Storb R
    Exp Hematol; 2003 Feb; 31(2):168-75. PubMed ID: 12591282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total body irradiation and cyclophosphamide plus antithymocyte globulin regimen is well tolerated and promotes stable engraftment as a preparative regimen before T cell-replete haploidentical transplantation for acute leukemia.
    Fu H; Xu L; Liu D; Liu K; Zhang X; Chen H; Chen Y; Han W; Wang Y; Wang J; Wang F; Huang X
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1176-82. PubMed ID: 24747336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required.
    Zaucha JM; Zellmer E; Georges G; Little MT; Storb R; Storer B; Torok-Storb B
    Biol Blood Marrow Transplant; 2001; 7(11):613-9. PubMed ID: 11760149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates.
    Hogan WJ; Little MT; Zellmer E; Friedetzky A; Diaconescu R; Gisburne S; Lee R; Kuhr C; Storb R
    Biol Blood Marrow Transplant; 2003 Aug; 9(8):489-95. PubMed ID: 12931117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation.
    Deeg HJ; Amylon ID; Harris RE; Collins R; Beatty PG; Feig S; Ramsay N; Territo M; Khan SP; Pamphilon D; Leis JF; Burdach S; Anasetti C; Hackman R; Storer B; Mueller B
    Biol Blood Marrow Transplant; 2001; 7(4):208-15. PubMed ID: 11349807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Everolimus in combination with cyclosporin a as pre- and posttransplantation immunosuppressive therapy in nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Junghanss C; Rathsack S; Wacke R; Weirich V; Vogel H; Drewelow B; Mueller S; Altmann S; Freund M; Lange S
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1061-8. PubMed ID: 22182476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.